Global Biologic Therapeutics Market Report 2021-2025 – Strong R&D Pipeline, Patent Expiry of Major Biologics, and Increasing Investment in Development of Biologics – ResearchAndMarkets.com

Global Biologic Therapeutics Market Report 2021-2025 – Strong R&D Pipeline, Patent Expiry of Major Biologics, and Increasing Investment in Development of Biologics – ResearchAndMarkets.com




Global Biologic Therapeutics Market Report 2021-2025 – Strong R&D Pipeline, Patent Expiry of Major Biologics, and Increasing Investment in Development of Biologics – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Biologic Therapeutics Market 2021-2025” report has been added to ResearchAndMarkets.com’s offering.

The biologic therapeutics market is poised to grow by $226.61 bn during 2021-2025, progressing at a CAGR of 11.00%

The market is driven by strong R&D pipeline, patent expiry of major biologics, and increasing investment in development of biologics.

The report provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The biologic therapeutics market analysis includes product and geographic landscape.

This study identifies the introduction of biosimilars as one of the prime reasons driving the biologic therapeutics market growth during the next few years. Also, the increasing incidence of chronic diseases and immunological disorders and patent expiry of major biologics will lead to sizable demand in the market.

The publisher’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biologic therapeutics market vendors that include AbbVie Inc., AstraZeneca Plc, Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson and Johnson Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., and Sanofi SA.

Also, the biologic therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Key Topics Covered:

Executive Summary

  • Market overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 – 2025

Five Forces Analysis

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product
  • Antibody therapeutics – Market size and forecast 2020-2025
  • Vaccines – Market size and forecast 2020-2025
  • Cell therapy – Market size and forecast 2020-2025
  • Gene therapy – Market size and forecast 2020-2025
  • Other therapies – Market size and forecast 2020-2025
  • Market opportunity by Product

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • Key leading countries
  • Market opportunity By Geographical Landscape
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc.
  • AstraZeneca Plc
  • Bristol-Myers Squibb Co.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Johnson and Johnson Inc.
  • Merck and Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA

Appendix

For more information about this report visit https://www.researchandmarkets.com/r/wraafh

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900